🇧🇷 Oxervate in Brazil

Oxervate (CENEGERMIN) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Oxervate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Brazil

Frequently asked questions

Is Oxervate approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Oxervate in Brazil?

Dompe farmaceutici s.p.a. is the originator. The local marketing authorisation holder may differ — check the official source linked above.